Acquired Brain Injury, Hyperbaric Oxygen Therapy, Motor Disability, Neuroprotective, Pediatric
Conditions
Brief summary
This study aimed to assess the efficacy of hyperbaric oxygen therapy as a neuroprotective intervention in children with acquired brain injury.
Detailed description
Pediatric acquired brain injury (ABI) represents a significant challenge in modern medicine, necessitating innovative therapeutic approaches to enhance recovery and minimize long-term neurological deficits. Hyperbaric oxygen therapy (HBOT), which delivers oxygen at pressures exceeding atmospheric levels, has emerged as a promising neuroprotective intervention for various forms of pediatric brain injury, including traumatic brain injury (TBI), anoxic-ischaemic encephalopathy (AIE), and stroke.
Interventions
Patients received hyperbaric oxygen therapy using a monochamber hyperbaric chamber in addition to conventional rehabilitation.
Patients received conventional rehabilitation alone.
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 4-12 years. * Diagnosed with pediatric acquired brain injury confirmed by neurological examination and magnetic resonance imaging. * Presence of neurological sequelae (e.g., cardiac arrest, intracranial hemorrhage, central nervous system infection, stroke, tumor, hypoxia).
Exclusion criteria
* Positive family history of degenerative brain insults. * Behavioral problems. * Contraindications to hyperbaric oxygen therapy : * Active epilepsy. * Respiratory insufficiency. * Uncontrolled heart failure. * Eustachian tube dysfunction. * Tympanic membrane rupture. * Mechanical ventilation dependency.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Spasticity assessment | Eight months post-intervention | Spasticity assessment was conducted utilizing the Modified Ashworth Scale (MAS), which quantified resistance during passive soft tissue stretching. * Grade 0: No increase in muscle tone. * Grade 1: Slight increase in tone, minimal resistance. * Grade 2: More marked increase, resistance through most ROM. * Grade 3: Considerable increase, passive movement difficult. * Grade 4: Rigidity in flexion/extension. * Grade 5: Rigidity preventing passive movement. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate changes in gross motor function temporally | Eight months post-intervention | The Gross Motor Function Measure (GMFM) was utilized to evaluate changes in gross motor function temporally. This standardized assessment specifically quantified task completion capability rather than qualitative performance metrics. * Level I: Independent ambulation without limitations. * Level II: Walks without assistance but with limitations (e.g., uses handrails). * Level III: Walks with assistive devices (e.g., walker). * Level IV: Non-ambulatory but can move independently on hands and knees. * Level V: Complete dependence on a manual wheelchair for mobility. |
| Upper limb function assessment | Eight months post-intervention | Upper limb function assessment (ULFA) was evaluated utilizing the Gordon and Duff Scale, which employed a six-point classification system (Types 0-5). * Type 0: No active upper extremity function. * Type 1: Minimal active movement, no functional use. * Type 2: Partial grasp and release, limited thumb opposition. * Type 3: Functional grasp but impaired precision tasks. * Type 4: Normal function with slight limitations (e.g., reduced speed). * Type 5: Normal or near-normal function with entire thumb opposition. |
| Assessment the fine motor function progression | Eight months post-intervention | The Manual Ability Classification System (MACS) was implemented to assess fine motor function progression. * Level I: Handles objects easily and successfully. * Level II: Handles most objects with minor adaptations. * Level III: Handles objects with difficulty and requires assistance. * Level IV: Handles very few objects, highly dependent. * Level V: Does not handle objects and requires full support. |
| Evaluate feeding capabilities | Eight months post-intervention | The Eating and Drinking Ability Classification System (EDACS) was employed to evaluate feeding capabilities. * Level I: Safe and efficient oral intake without assistance. * Level II: Minor dietary restrictions or compensatory strategies. * Level III: Moderate dietary restrictions and assistance. * Level IV: Requires alternative feeding methods (e.g., gastrostomy). * Level V: Complete dependence on non-oral feeding. |
Countries
Egypt